title: Enhancing blood-stage malaria subunit vaccine immunogenicity in rhesus macaques by combining adenovirus, poxvirus, and protein-in-adjuvant vaccines.
abstract: Protein-in-adjuvant formulations and viral-vectored vaccines encoding blood-stage malaria Ags have shown efficacy in rodent malaria models and in vitro assays against Plasmodium falciparum. Abs and CD4(+) T cell responses are associated with protective efficacy against blood-stage malaria, whereas CD8(+) T cells against some classical blood-stage Ags can also have a protective effect against liver-stage parasites. No subunit vaccine strategy alone has generated demonstrable high-level efficacy against blood-stage infection in clinical trials. The induction of high-level Ab responses, as well as potent T and B cell effector and memory populations, is likely to be essential to achieve immediate and sustained protective efficacy in humans. This study describes in detail the immunogenicity of vaccines against P. falciparum apical membrane Ag 1 in rhesus macaques (Macaca mulatta), including the chimpanzee adenovirus 63 (AdCh63), the poxvirus modified vaccinia virus Ankara (MVA), and protein vaccines formulated in Alhydrogel or CoVaccine HT adjuvants. AdCh63-MVA heterologous prime-boost immunization induces strong and long-lasting multifunctional CD8(+) and CD4(+) T cell responses that exhibit a central memory-like phenotype. Three-shot (AdCh63-MVA-protein) or two-shot (AdCh63-protein) regimens induce memory B cells and high-titer functional IgG responses that inhibit the growth of two divergent strains of P. falciparum in vitro. Prior immunization with adenoviral vectors of alternative human or simian serotype does not affect the immunogenicity of the AdCh63 apical membrane Ag 1 vaccine. These data encourage the further clinical development and coadministration of protein and viral vector vaccine platforms in an attempt to induce broad cellular and humoral immune responses against blood-stage malaria Ags in humans.
authors.affiliation: Jenner Institute, University of Oxford, Oxford, OX3 7DQ, United Kingdom. simon.draper@ndm.ox.ac.uk
authors.forename: Simon J
authors.initials: SJ
authors.lastname: Draper
authors.forename: Sumi
authors.initials: S
authors.lastname: Biswas
authors.forename: Alexandra J
authors.initials: AJ
authors.lastname: Spencer
authors.forename: Edmond J
authors.initials: EJ
authors.lastname: Remarque
authors.forename: Stefania
authors.initials: S
authors.lastname: Capone
authors.forename: Mariarosaria
authors.initials: M
authors.lastname: Naddeo
authors.forename: Matthew D J
authors.initials: MD
authors.lastname: Dicks
authors.forename: Bart W
authors.initials: BW
authors.lastname: Faber
authors.forename: Simone C
authors.initials: SC
authors.lastname: de Cassan
authors.forename: Antonella
authors.initials: A
authors.lastname: Folgori
authors.forename: Alfredo
authors.initials: A
authors.lastname: Nicosia
authors.forename: Sarah C
authors.initials: SC
authors.lastname: Gilbert
authors.forename: Adrian V S
authors.initials: AV
authors.lastname: Hill
mesh_terms: D000256:Adenoviridae; D000276:Adjuvants, Immunologic; D000818:Animals; D000913:Antibodies, Protozoan / Q000276:immunology; D000953:Antigens, Protozoan / Q000276:immunology*; D001402:B-Lymphocytes / Q000276:immunology; D015496:CD4-Positive T-Lymphocytes / Q000276:immunology; D006801:Humans; D007111:Immunity, Cellular / Q000276:immunology*; D056724:Immunity, Humoral / Q000276:immunology*; D007074:Immunoglobulin G / Q000276:immunology; D007156:Immunologic Memory / Q000276:immunology; D008253:Macaca mulatta; D017780:Malaria Vaccines / Q000276:immunology*; D016778:Malaria, Falciparum / Q000276:immunology / Q000517:prevention & control*; D008565:Membrane Proteins / Q000276:immunology*; D051379:Mice; D010963:Plasmodium falciparum / Q000276:immunology*; D011212:Poxviridae; D015800:Protozoan Proteins / Q000276:immunology*; D022223:Vaccines, Subunit / Q000276:immunology; D014616:Vaccinia virus
chemical_list: D000276:Adjuvants, Immunologic; D000913:Antibodies, Protozoan; D000953:Antigens, Protozoan; D007074:Immunoglobulin G; D017780:Malaria Vaccines; D008565:Membrane Proteins; D015800:Protozoan Proteins; D022223:Vaccines, Subunit; C090077:apical membrane antigen I, Plasmodium